Package 0169-2911-15

{"route": ["SUBCUTANEOUS"], "spl_id": "7ade72ef-d354-430d-afad-3b63b95f5b39", "openfda": {"nui": ["M0011417", "N0000175453", "N0000178480", "M0160181", "N0000020058"], "unii": ["54Q18076QB", "839I73S42A"], "rxcui": ["1860167", "1860172"], "spl_set_id": ["21335fe4-d395-4501-ac2a-2f20d7520da9"], "pharm_class_cs": ["Insulin [CS]", "Glucagon-Like Peptide 1 [CS]"], "pharm_class_epc": ["Insulin Analog [EPC]", "GLP-1 Receptor Agonist [EPC]"], "pharm_class_moa": ["Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"], "manufacturer_name": ["Novo Nordisk"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 SYRINGE, PLASTIC in 1 CARTON (0169-2911-15)  / 3 mL in 1 SYRINGE, PLASTIC", "package_ndc": "0169-2911-15", "marketing_start_date": "20161121"}], "brand_name": "Xultophy 100/3.6", "product_id": "0169-2911_7ade72ef-d354-430d-afad-3b63b95f5b39", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["GLP-1 Receptor Agonist [EPC]", "Glucagon-Like Peptide 1 [CS]", "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]", "Insulin Analog [EPC]", "Insulin [CS]"], "product_ndc": "0169-2911", "generic_name": "insulin degludec and liraglutide", "labeler_name": "Novo Nordisk", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Xultophy 100/3.6", "active_ingredients": [{"name": "INSULIN DEGLUDEC", "strength": "100 [iU]/mL"}, {"name": "LIRAGLUTIDE", "strength": "3.6 mg/mL"}], "application_number": "BLA208583", "marketing_category": "BLA", "marketing_start_date": "20161121", "listing_expiration_date": "20261231"}